thorax.bmj2d
Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)
9 European Union (EU) Innovative Medicines Initiative (IMI) Program Understanding Severe Asthma, Consortium Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) ...
thorax.bmj2d
Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study
12 Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada Correspondence to Dr Wan C Tan, UBC James Hogg Research Centre, Providence Heart+Lung Institute, University of ...
thorax.bmj2d
Gene expression networks in COPD: microRNA and mRNA regulation
1 Department of Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, Ohio, USA Background The mechanisms underlying chronic obstructive ...
thorax.bmj2d
Non-coding RNA as lung disease biomarkers
Correspondence to Professor Catherine M Greene, Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, ...
thorax.bmj2d
S103 Clinical effectiveness of tezepelumab on upper and lower respiratory symptoms in patients with asthma and co-morbid nasal polyposis
Introduction Chronic rhinosinusitis with nasal polyposis (CRSwNP) affects a significant proportion of people with severe asthma (SA). Despite the effectiveness of anti-IL5/5R therapies in the ...
thorax.bmj2d
P120 Evaluating the use of the NEWS2 SpO2 Scales in COPD patients admitted to medical wards: a prospective clinical audit
Objective NEWS2 (RCP 2017) 1 recommends use of ‘SpO2 Scale 2’ in patients with hypercapnic respiratory failure (usually due to COPD) to aim target saturations of 88–92%. We aimed to identify if COPD ...
thorax.bmj3d
Chronic obstructive pulmonary disease • 1: Susceptibility factors for COPD the genotype–environment interaction
2 Channing Laboratory and Pulmonary and Critical Care Division, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA This work was supported by NIH grants HL 61575 and HL 68926 ...
thorax.bmj4d
The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status
2 School of Public Health and Psychosocial Studies and School of Rehabilitation and Occupational Studies, AUT University, Auckland, New Zealand 3 Department of Dermatology, King's College Hospital, ...
thorax.bmj4d
Which COPD patients should be admitted to the ICU?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
thorax.bmj4d
Pulmonary sarcoidosis with an alveolar radiographic pattern.
Thirty-three cases of sarcoidosis (4.4% of 746 patients) showed an alveolar radiological pattern. A study of pulmonary function was carried out in 25 patients and compared with that of 46 patients ...
thorax.bmj4d
High-intensity training following lung cancer surgery: a randomised controlled trial
Correspondence to Elisabeth Edvardsen, Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, P.O. Box 4953 Nydalen, 0424 Oslo, Norway; elisabeth.edvardsen{at}nih.no Background Many ...
thorax.bmj5d
How much asthma is really attributable to atopy?
a Wellington Asthma Research Group, Wellington School of Medicine, P.O. Box 7343, Wellington, New Zealand, b Unit of Environmental Epidemiology, National Public Health Institute, P. O. Box 95, Kuopio, ...